RPS Secures $28 Million Financing with OrbiMed
Business
SRQ DAILY FRESHLY SQUEEZED CONTENT EVERY MORNING
TUESDAY OCT 14, 2014 |
RPS Diagnostics, a developer, manufacturer and marketer of rapid point-of-care diagnostic tests, announced the closing of $28 million of non-dilutive debt financing with OrbiMed. This and other preceding financing allow RPS significant flexibility as it continues to grow and advance toward profitability. The combination of RPS’s strong intellectual property and technology platforms facilitates the development of easy-to-use tests that target critical and unmet healthcare needs in the diagnostic marketplace.
« View The Tuesday Oct 14, 2014 SRQ Daily Edition
« Back To SRQ Daily Archive
